Patents Assigned to FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON, FUNDACIÓ PRIVADA
  • METHODS AND KITS FOR THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20130171653
    Abstract: The present invention relates to the use of PSGR, a member of the G-protein-coupled olfactory receptor family which is over-expressed in prostate cancer tissue, as a marker suitable for an urine-based diagnostic test for prostate cancer which require only typical prostate manipulation and sample acquisition scenarios avoiding invasive tissue collection.
    Type: Application
    Filed: July 14, 2011
    Publication date: July 4, 2013
    Applicant: FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON, FUNDACIÓ PRIVADA
    Inventors: Andreas Doll, Marina Rigau Resina, Miguel Abal Posada, Juan Morote Robles, Jaume Reventós Puigjaner
  • MARKERS FOR SELECTING PERSONALIZED THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20120231020
    Abstract: The invention relates to the identification of aprataxin (APTX) expression levels as a marker for the response to topoisomerase I inhibitor-based therapies in patients with cancer and, more particularly, colon cancer. The invention also relates to methods for treating patients with cancer who have low APTX expression levels by means of administering a topoisomerase I inhibitor to said patients.
    Type: Application
    Filed: September 1, 2010
    Publication date: September 13, 2012
    Applicant: Fundacio Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada
    Inventors: Diego Arango Del Corro, Simó Schwartz Navarro, John Martin Mariadason